pyrazolanthrone has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Borst, MH; Hamming, I; Klok, PA; Kok, RJ; Navis, G; Prakash, J; Sandovici, M; van Goor, H | 1 |
| Coimbra, TM; Costa, RS; Francescato, HD; Júnior, FB | 1 |
| Guan, QH; Ji, HX; Pei, DS; Wang, Y; Xing, SH | 1 |
3 other study(ies) available for pyrazolanthrone and Kidney Diseases
| Article | Year |
|---|---|
c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
Topics: Adolescent; Adult; Animals; Anthracenes; Blotting, Western; Cell Line; Chemokine CCL2; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Epithelial Cells; Female; Gene Expression; Humans; Immunohistochemistry; Inflammation; JNK Mitogen-Activated Protein Kinases; Kidney Diseases; Kidney Tubules; Macrophages; Male; Middle Aged; Nephritis, Interstitial; Protein Kinase Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Young Adult | 2009 |
Effect of JNK inhibition on cisplatin-induced renal damage.
Topics: Animals; Anthracenes; Apoptosis; Cisplatin; Glomerular Filtration Rate; Inflammation; Kidney; Kidney Diseases; Lipid Peroxidation; Male; MAP Kinase Kinase 4; Necrosis; Protein Kinase Inhibitors; Rats; Rats, Wistar | 2007 |
SP600125, a selective JNK inhibitor, protects ischemic renal injury via suppressing the extrinsic pathways of apoptosis.
Topics: Animals; Anthracenes; Apoptosis; Disease Models, Animal; JNK Mitogen-Activated Protein Kinases; Kidney; Kidney Diseases; Necrosis; Protective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2007 |